Document is current
Any future updates will be listed below
-
Authors
Popescu, Dorin-Mirel
Botting, Rachel A.
Stephenson, Emily
Green, Kile
Webb, Simone
Jardine, Laura
Calderbank, Emily F.
Polanski, Krzysztof
Goh, Issac
Efremova, Mirjana
Acres, Meghan
Maunder, Daniel
Vegh, Peter
Gitton, Yorick
Park, Jong-Eun
Vento-Tormo, Roser
Miao, Zhichao
Dixon, David
Rowell, Rachel
McDonald, David
Fletcher, James
Poyner, Elizabeth
Reynolds, Gary
Mather, Michael
Moldovan, Corina
Mamanova, Lira
Greig, Frankie
Young, Matthew D.
Meyer, Kerstin B.
Lisgo, Steven
Bacardit, Jaume
Fuller, Andrew
Millar, Ben
Innes, Barbara
Lindsay, Susan
Stubbington, Michael J. T.
Kowalczyk, Monika S.
Li, Bo
Ashenberg, Orr
Tabaka, Marcin
Dionne, Danielle
Tickle, Timothy L.
Slyper, Michal
Rozenblatt-Rosen, Orit
Filby, Andrew
Carey, Peter
Villani, Alexandra-Chloé
Roy, Anindita
Regev, Aviv
Chédotal, Alain
Roberts, Irene
Göttgens, Berthold
Behjati, Sam
Laurenti, Elisa
Teichmann, Sarah A.
Haniffa, Muzlifah
- License Information
-
More Information
Article History
Received: 26 October 2018
Accepted: 9 September 2019
First Online: 9 October 2019
Competing interests
: A. Regev is a founder and equity holder of Celsius Therapeutics and an SAB member of Neogene Therapeutics, ThermoFisher Scientific and Syros Pharmaceuticals.
